Teva’s Barr Labs settles Cipro antitrust case for $225 million | International News Live Blog

https://internationalnewsliveblog.wordpress.com/2017/01/27/tevas-barr-labs-settles-cipro-antitrust-case-for-225-million/

(Reuters) – Teva Pharmaceutical Industries Ltd’s Barr Laboratories Inc has reached a $225 million settlement in an antitrust class action that accused the drugmaker of keeping a generic version of Bayer AG’s antibiotic Cipro off the market, court documents showed. http://internationalnewslive.com/tevas-barr-labs-settles-cipro-antitrust-case-for-225-million/